Nordtreat

Vantaa, Finland

Nordtreat produces the world's first bio-based flame retardant technology, NORFLAMAE, for wood-based materials.

$10.7M raised

Jun 2024

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Nordtreat raised?

Nordtreat has raised $10.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2024.

Who are Nordtreat's investors?

Nordtreat's investors include UB FIGG, Altana, Taaleri Bioindustry, Taaleri.

Where is Nordtreat headquartered?

Nordtreat is headquartered in Vantaa, Finland.

What does Nordtreat do?

Nordtreat produces the world's first bio-based flame retardant technology, NORFLAMAE, for wood-based materials.

What stage is Nordtreat at?

Nordtreat is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 20, 2024.

MLA

"Nordtreat — Funding & Investors." VCBacked, June 20, 2024, https://www.vcbacked.co/company/nordtreat. Accessed July 2, 2026.

APA

VCBacked. (2024). Nordtreat — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/nordtreat

Wikipedia (cite web)

{{cite web |title=Nordtreat — Funding & Investors |url=https://www.vcbacked.co/company/nordtreat |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 20, 2024.